Background/Objectives: The growing issue of clinical obesity has led to increased consumption of weight-loss dietary supplements containing hydroxycitric acid (HCA) derived from the fruit rind of Garcinia cambogia, a plant widely distributed in Asia and Africa. It is often consumed in an unregulated manner, beyond the permissible dose, to achieve the target weight-loss. However, its safety/efficacy is controversial and reports on cytotoxicity and genotoxicity are limited and inconsistent. Hence, we aimed to study the putative effects of HCA on genotoxicity in human peripheral blood cells.
Methods:Human lymphocytes and erythrocytes were treated with HCA (0, 10, 20, 40 or 100 µg/mL) for 3 h or 24 h and processed for cytotoxicity and genotoxicity analyses.Results: Initial phytochemical assessment of HCA revealed the presence of high flavonoid content. Subsequent multiendpoint cyto-genotoxicity studies in human lymphocytes displayed low cytotoxicity but significant genotoxicity at higher concentrations of 40 and 100 µg/mL; these concentrations are approximately equivalent to and double the maximum permissible dose (∼2800 mg/day), respectively. Flow cytometric estimation of reactive oxygen species (ROS), mitochondrial membrane potential (ΔΨm) and mode of cell death revealed significant ROS generation at the higher concentrations, but no effect on ΔΨm and apoptosis/necrosis. Insignificant hemolysis was observed in erythrocytes.
Conclusions:High flavonoid content of HCA potentially imparts pro-oxidant property, facilitating DNA damage at high concentrations. However, such genotoxicity does not lead to cell death. Therefore, HCA can be recommended for safe consumption within the permissible dose limit.